Skip to main content
. 2019 Nov 14;10:2612. doi: 10.3389/fimmu.2019.02612

Table 3B.

The expressions of 18 macrophage subset transcription factors and 27 macrophage general transcription factors are modulated in 8 groups of 34 diseases.

Autoimmune diseases Cardiovascular diseases Digestive inflammatory Infection diseases Metabolic diseases Respiratory diseases Digestive tumors Other tumors Up-regulated disease Down-regulated disease
Subsets TFs 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 Number % Number %
M1 HIF1A 6 17.6 6 17.6
RELA 1 2.9 2 5.9
IRF3 2 5.9 2 5.9
STAT1 17 50.0 2 5.9
STAT2 9 26.5 2 5.9
M2a PPARD 8 23.5 3 8.8
PPARG 7 20.6 9 26.5
KLF4 1 2.9 13 38.2
AKT1 1 2.9 1 2.9
M2b MAPK1 5 14.7 4 11.8
STAT3 8 23.5 4 11.8
M2c NFKB1 1 2.9 2 5.9
NFKB2 6 17.6 2 5.9
NR3C1 3 8.8 11 32.4
NFE2 6 17.6 4 11.8
Mhb ATF1 2 5.9 6 17.6
Mox NR1H3 4 11.8 2 5.9
Mhem NR1H2 3 8.8 3 8.8
NR1H3 4 11.8 2 5.9
uncertain CREB1 4 11.8 5 14.7
HMGA1 11 32.4 2 5.9
SMAD4 3 8.8 13 38.2
ZNF148 3 8.8 5 14.7
HBP1 1 2.9 7 20.6
CKLF 8 23.5 4 11.8
ZNF281 9 26.5 1 2.9
FOXO3 0 0.0 6 17.6
HEY1 8 23.5 8 23.5
ETS2 6 17.6 11 32.4
HIF1A 8 23.5 4 11.8
STAT4 2 5.9 2 5.9
MELTF 7 20.6 2 5.9
BATF3 3 8.8 0 0.0
NFE2 6 17.6 4 11.8
NFKB1 1 2.9 2 5.9
RIT1 8 23.5 5 14.7
HIVEP1 2 5.9 2 5.9
JUNB 4 11.8 7 20.6
NFX1 4 11.8 3 8.8
FOXN3 1 2.9 12 35.3
STAT3 7 20.6 6 17.6
PWWP3A 0 0.0 0 0.0
MXD4 1 2.9 5 14.7
E2F3 13 38.2 1 2.9
CEBPD 2 5.9 6 17.6
NME1 12 35.3 4 11.8
Up-
regulated gene
Number 5 0 4 1 8 18 0 4 7 1 9 18 0 2 2 7 2 1 2 2 0 7 0 4 8 9 5 17 13 6 5 13 19 12
% 12.2 0.0 9.8 2.4 19.5 43.9 0.0 9.8 17.1 2.4 22.0 43.9 0.0 4.9 4.9 17.1 4.9 2.4 4.9 4.9 0.0 17.1 0.0 9.8 19.5 22.0 12.2 41.5 31.7 14.6 12.2 31.7 46.3 26.8
Down-regulated gene Number 9 1 1 1 6 4 8 18 2 0 4 8 28 0 0 6 12 0 6 3 0 2 0 1 5 2 11 3 6 9 10 10 13 4
% 20.0 2.2 2.2 2.2 13.3 8.9 17.8 40.0 4.4 0.0 8.9 17.8 62.2 0.0 0.0 13.3 26.7 0.0 13.3 6.7 0.0 4.4 0.0 2.2 11.1 4.4 24.4 6.7 13.3 20.0 22.2 22.2 28.9 8.9

First, some Mφ transcription factors (TFs) were upregulated in more than 30% of the 34 diseases, including M1 TF STAT1 and three other Mφ TFs, namely HMGA1, E2F3, and NME1. Second, the diseases having Mφ TFs upregulated in more than 30% among the 34 diseases were of six types, namely #6 coronary artery disease, #12 Crohn's colitis, #28 hepatocellular cancer, #29 esophageal cancer, #32 ovarian carcinoma, and #33 lung cancer (For detailed expression data, see the Figures S13S16). 1, Rheumatoid arthritis; 2, Systemic lupus erythematosus; 3, Psoriasis; 4, Asthma; 5, Myocardial infarction; 6, Coronary artery disease; 7, Abdominal aortic aneurysm; 8, Aortic occlusive disease; 9, Ulcerative colitis; 10, Gastritis; 11, Crohn's ileitis; 12, Crohn's colitis; 13, Tuberculous Meningitis coinfected with HIV; 14, Sepsis; 15, Chronic Hepatitis C virus; 16, Tuberculosis; 17, Type 2 diabetes; 18, Type 1 diabetes; 19, Metabolic syndrome; 20, Familial Hypercholesterolemia; 21, Chronic obstructive pulmonary disease; 22, Pulmonary arterial hypertension; 23, Asthma; 24, Pneumonia; 25, Gastric adenocarcinoma; 26, Hepatocellular cancer; 27, Colorectal adenocarcinoma; 28, Pancreatic cancer; 29, Esophageal cancer; 30, Breast Adenocarcinoma; 31, Prostate cancer; 32, Ovarian carcinoma; 33, Lung cancer; 34, Renal carcinoma.